Evidence map›Paper›PMID 35656140›Full record

ArticleChemical science2022

Development of a fluorescent probe library enabling efficient screening of tumour-imaging probes based on discovery of biomarker enzymatic activities.

Yugo Kuriki, Takafusa Yoshioka, Mako Kamiya, Toru Komatsu, Hiroyuki Takamaru, Kyohhei Fujita, Hirohisa Iwaki, Aika Nanjo, Yuki Akagi, Kohei Takeshita and 9 more

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yugo KurikiGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.
Takafusa YoshiokaGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.
Mako KamiyaGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-5592-1849
Toru KomatsuGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-9268-6964
Hiroyuki TakamaruEndoscopy Division, National Cancer Center Hospital 5-1-1, Tsukiji Chuo-ku Tokyo Japan.
Kyohhei FujitaGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.
Hirohisa IwakiGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.
Aika NanjoGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.
Yuki AkagiInstitute of Engineering, Tokyo University of Agriculture and Technology 2-24-16 Naka-cho Koganei-shi Tokyo Japan.
Kohei TakeshitaGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0003-0164-6383
Haruaki HinoGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-6048-6319
Rumi HinoDaito Bunka University, Department of Sports and Health Science 560, Iwadono Higashimatsuyama Saitama Japan.ORCID https://orcid.org/0000-0003-4519-2926
Ryosuke KojimaGraduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan mkamiya@m.u-tokyo.ac.jp uranokun@m.u-tokyo.ac.jp.ORCID https://orcid.org/0000-0002-3792-9222
Tasuku UenoGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0001-6657-8209
Kenjiro HanaokaGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0003-0797-4038
Seiichiro AbeEndoscopy Division, National Cancer Center Hospital 5-1-1, Tsukiji Chuo-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-2736-6921
Yutaka SaitoEndoscopy Division, National Cancer Center Hospital 5-1-1, Tsukiji Chuo-ku Tokyo Japan.ORCID https://orcid.org/0000-0003-2296-8373
Jun NakajimaDepartment of Thoracic Surgery, Graduate School of Medicine, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0003-1174-0816
Yasuteru UranoGraduate School of Pharmaceutical Sciences, The University of Tokyo 7-3-1, Hongo Bunkyo-ku Tokyo Japan.ORCID https://orcid.org/0000-0002-1220-6327

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluorescent probes that can selectively detect tumour lesions have great potential for fluorescence imaging-guided surgery. Here, we established a library-based approach for efficient screening of probes for tumour-selective imaging based on discovery of biomarker enzymes. We constructed a combinatorial fluorescent probe library for aminopeptidases and proteases, which is composed of 380 probes with various substrate moieties. Using this probe library, we performed lysate-based

Identifiers

PMID35656140
PMCPMC9019911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.